|
|
| | Etonitazene-d5 Basic information |
| | Etonitazene-d5 Chemical Properties |
| solubility | DMF: 25 mg/ml
DMF: PBS (pH 7.2) (1:1): 0.5 mg/ml
DMSO: 20 mg/ml
Ethanol: 10 mg/ml |
| | Etonitazene-d5 Usage And Synthesis |
| Description | Etonitazene-d5 (Item No. 31134) is an analytical reference standard intended for use as an internal standard for the quantification of etonitazene (Item No. 21824) by GC- or LC-MS. Etonitazene is categorized as an opioid.1,2,3 Etonitazene has analgesic effects in mice.4 Etonitazene-d5 is regulated as a Schedule I compound in the United States. This product is intended for research and forensic applications.WARNING This product is not for human or veterinary use. | | References | [1] PETER BLANCKAERT. Report on a novel emerging class of highly potent benzimidazole NPS opioids: Chemical and in vitro functional characterization of isotonitazene[J]. Drug Testing and Analysis, 2019, 12 4: 422-430. DOI: 10.1002/dta.2738
[2] MARJORIE S. MOOLTEN. Etonitazene: An opioid selective for the mu receptor types[J]. Life sciences, 1993, 52 18: Pages PL199-PL203. DOI: 10.1016/0024-3205(93)90118-m
[3] MARTHE M. VANDEPUTTE. Synthesis, Chemical Characterization, and μ-Opioid Receptor Activity Assessment of the Emerging Group of “Nitazene” 2-Benzylbenzimidazole Synthetic Opioids.[J]. ACS Chemical Neuroscience, 2021. DOI: 10.22541/au.160520665.59016513/v2
[4] ISTVÁN UJVÁRY*. DARK Classics in Chemical Neuroscience: Etonitazene and Related Benzimidazoles[J]. ACS Chemical Neuroscience, 2021, 12 7: 1072-1092. DOI: 10.1021/acschemneuro.1c00037 |
| | Etonitazene-d5 Preparation Products And Raw materials |
|